de Groot Bas, Verdoorn Ruben C W, Lameijer Joost, van der Velden Jolanda
SEH, Leiden University Medical Centre, Leiden, Zuid Holland, The Netherlands.
Vrije Universiteit Medical Centre, Amsterdam, The Netherlands.
Emerg Med J. 2014 Nov;31(11):882-8. doi: 10.1136/emermed-2013-202865. Epub 2013 Aug 21.
To assess the prognostic and discriminative accuracy of high-sensitivity cardiac troponin T (hs-cTnT) for prediction of inhospital mortality in emergency department (ED) patients with suspected infection.
Prospective observational derivation study in ED patients with suspected infection. Prognostic performance of hs-cTnT (divided in four quartiles because of non-linearity) for prediction of inhospital mortality was assessed using multivariable logistic regression, correcting for predisposition, infection, response and organ failure (PIRO) score as a measure of illness severity and quality of ED treatment as quantified by the number of 'Surviving Sepsis Campaign' goals achieved. Discriminative power of hs-cTnT was assessed by receiver operator characteristics with area under the curve (AUC) analysis.
Hs-cTnT (median (IQR) was 57 (25-90) ng/L (n=23) in non-survivors, significantly higher than the 15 (7-28) ng/L in survivors (n=269, p<0.001). Additionally, the lowest quartile of hs-cTnT was a perfect predictor of survival because zero death occurred. Therefore, the second quartile was used as a reference category in the multivariable logistic regression analysis showing that hs-cTnT was an independent predictor of inhospital mortality: Corrected ORs were 2.2 (95% CI 0.4 to 12.1) and 5.8 (1.2 to 27.3) for the 3rd and 4th quartile compared with the 2nd hs-cTnT quartile. The AUCs of hs-TnT was 0.81 (0.74 to 0.88), similar to the AUC of 0.78 (0.68 to 0.87) of the PIRO score (p>0.05). Overall negative predictive value of hs-cTnT was 99%.
In ED patients with suspected infection, the routinely used biomarker hs-cTnT is an independent predictor of inhospital mortality with excellent discriminative performance. Future studies should focus on the additional value of hs-cTnT to existing risk stratification tools.
评估高敏心肌肌钙蛋白T(hs-cTnT)对预测急诊科(ED)疑似感染患者院内死亡率的预后及判别准确性。
对ED疑似感染患者进行前瞻性观察性推导研究。使用多变量逻辑回归评估hs-cTnT(因非线性分为四个四分位数)预测院内死亡率的预后性能,校正易感性、感染、反应和器官功能衰竭(PIRO)评分作为疾病严重程度的指标,并将实现的“拯救脓毒症运动”目标数量作为ED治疗质量的量化指标。通过曲线下面积(AUC)分析的受试者工作特征曲线评估hs-cTnT的判别能力。
非幸存者的hs-cTnT中位数(IQR)为57(25-90)ng/L(n = 23),显著高于幸存者的15(7-28)ng/L(n = 269,p<0.001)。此外,hs-cTnT的最低四分位数是生存的完美预测指标,因为无死亡发生。因此,在多变量逻辑回归分析中,将第二四分位数用作参考类别,结果显示hs-cTnT是院内死亡率的独立预测指标:与hs-cTnT第二四分位数相比,第三和第四四分位数的校正比值比分别为2.2(95%CI 0.4至12.1)和5.8(1.2至27.3)。hs-TnT的AUC为0.81(0.74至0.88),与PIRO评分的AUC 0.78(0.68至0.87)相似(p>0.05)。hs-cTnT的总体阴性预测值为99%。
在ED疑似感染患者中,常规使用的生物标志物hs-cTnT是院内死亡率的独立预测指标,具有出色的判别性能。未来研究应关注hs-cTnT对现有风险分层工具的附加价值。